LillyDirect
Eli Lilly’s direct-to-consumer channel selling Zepbound single-dose vials to cash payers — $299 at 2.5 mg, $399 at 5 mg, $449 at 7.5–15 mg — the price floor for approved tirzepatide and the benchmark every compounded figure on this site is measured against.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
Seen against the live index: with verified all-in prices spanning $215 to $597 for tirzepatide and $133 to $348 for semaglutide as of 2026-08-09, terms like this one are not pedantry — they are the difference between the advertised number and the billed one. Every definition in this glossary links back to the places in the database and the methodology where the concept does its work.
The concrete stakes today: the vial ladder ($299/$399/$449) is the ceiling every compounded tirzepatide price argues against. Related figures live on the pages this term links to, and every one of them regenerates from the same dataset this definition does.
See the term in action across the price database and the methodology.